Research & Labs

Cancer Researchers Awarded $4.6 Million to Advance Liquid Biopsy Test for Early Lung Cancer Detection

UCLA wins $4.6M NCI grant to advance EFIRM liquid biopsy, aiming to improve early, noninvasive detection of lung cancer in patients with lung nodules.

Cell therapy could improve bone marrow transplant safety

UCLA researchers report a step forward in the development of an “off-the-shelf” cell therapy that could reduce the severity of graft-versus-host d...

CIRM grant will help expand patients’ access to UCLA clinical trials for stem cell, gene therapies

A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-s...

Classification System for Reporting on Skin Biopsies of Melanocytic Lesions

International group updates a classification system that makes skin biopsy pathology reports easier for patients and medical teams to understand

Clinical Dietitian Pursues Basic Science Research to Help Patients

UCLA PhD student Rochelle Lai investigates ways for treating metabolic diseases at the cellular level.

Clinical Trial using Tecovirimat in Human Mpox Infection

This study is looking at the safety and efficacy of the medication, tecovirimat, for the treatment of Mpox infection.

Common antidepressants could help the immune system fight cancer, UCLA study finds

A widely used antidepressant drug could help the immune system fight cancer, according to a new UCLA research study.

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production

Counterfeit pills sold in Mexican pharmacies found to contain fentanyl, heroin, and methamphetamine

COVID-19 Scientific Prioritization and Feasibility Committee concludes after three years

Effective Oct. 1, UCLA Health no longer requires scientific review of COVID-related studies by the COVID-19 Scientific Prioritization and Feasibility Committee.

Crowdsourcing the brain: Meta-atlas reveals new clues about development and disease

A new UCLA study leverages computational methods and vast troves of existing data to bring us closer to developing new treatments for brain disorders.

Daily aspirin no longer recommended to prevent heart disease

Aspirin may be only ‘minimally beneficial’ and comes with an increased risk of digestive tract bleeding...

Determining How Nucleoside Metabolism Regulates Contrasting Immune Functions in the Rare Disease PNP Deficiency

The metabolic enzyme purine nucleoside phosphorylase (PNP) protects against immunodeficiency and regulates innate immune signaling via previously unkn...

DGSOM faculty members named among the world’s most influential researchers